Skip to main content

Table 2 Percentage and Incidence of Combined Resistance Phenotypes, Israel, 2014–2017

From: Trends in antimicrobial resistance in Israel, 2014–2017

  2014 2015 2016 2017
Bacterial name Percentage of resistant isolates Incidence per 100,000 patient-days Percentage of resistant isolates Incidence per 100,000 patient-days Percentage of resistant isolates Incidence per 100,000 patient-days Percentage of resistant isolates Incidence per 100,000 patient-days
A. baumannii Carb+FQ + AG 73.2 8.4 74.2 9.3 72.2 7.8 70.1 7.2
E. coli 3GC 29.5 24.1 32.0 30.2 32.4 32.3 32.0 32.4
E. coli 3GC + FQ + AG 10.6 8.7 10.3 9.7 9.3 9.1 8.3 8.2
K. pneumoniae 3GC + FQ + AG 23.7 8.0 20.8 7.6 20.7 8.3 19.2 8.0
K. pneumoniae Carb+Col 1.8 0.2 0.6 0.0 0.4 0.0 ND ND
  1. AG Aminoglycoside-resistant, Carb Carbapenem-resistant, Col Colistin-resistant, FQ Fluoroquinolone-resistant, 3GC 3rd-generation cephalosporin-resistant